LLY
$84.19
Eli Lilly
($.23)
(.27%)
LLY
Earnings Whisper ®
N/A
1st Quarter March 2017
Consensus:  $0.95
Revenue:  $5.23 Bil
Tuesday
May 2
6:25 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS
Tuesday, January 31, 2017

What do you expect when LLY reports earnings?
Beat
Meet
Miss

Where is LLY's stock price going from here?
Up
Flat
Down
Stock chart of LLY
Analysts
Summary of analysts' recommendations for LLY
Score
Grade
Pivots
Resistance
$86.14
$85.59
$85.01

$84.46

Support
$83.88
$83.33
$82.75
Tweet
Growth
Description
Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.
Peers
BioMarin PharmaceuticalJohnson & JohnsonRegeneron PharmaceuticalsVertex PharmaceuticalsCelgeneEndo International plcPfizerBristol-Myers SquibbInterCeptMerck & Co.